Safety of Topical Neuromodulators for the Treatment of Pruritus

JAMA Dermatol. 2016 Dec 1;152(12):1390-1391. doi: 10.1001/jamadermatol.2016.3118.

Authors

Michael A Cardis¹, Helena B Pasieka¹

Affiliation

¹ Department of Dermatology, MedStar Washington Hospital Center, Washington, DC2Department of Dermatology, MedStar Georgetown University Hospital, Washington, DC.

PMID: 27626772
DOI: 10.1001/jamadermatol.2016.3118

No abstract available

MeSH terms

Administration, Topical
Aged, 80 and over
Amitriptyline / administration & dosage*
Analgesics, Non-Narcotic / administration & dosage
Dose-Response Relationship, Drug
Drug Combinations
Humans
Ketamine / administration & dosage*
Male
Neurotransmitter Agents / administration & dosage*
Pruritus / diagnosis
Pruritus / drug therapy*
Skin / drug effects
Skin / pathology*
Treatment Outcome

Substances

Analgesics, Non-Narcotic
Drug Combinations
Neurotransmitter Agents
Amitriptyline
Ketamine